OSI News
OSI Funding for clinical trial at Dana-Farber and USCF
FOR IMMEDIATE RELEASE February 27, 2020 The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and University of California San Francisco The clinical trial will investigate the...
Funding for Clinical Trial and Preclinical Translational Biology Study
FOR IMMEDIATE RELEASE November 08, 2019 The Osteosarcoma Institute Announces Funding for Clinical Trial and Preclinical Translational Biology StudyDallas, TX — November 8, 2019 — The Osteosarcoma Institute (OSI) is pleased to announce funding support of a clinical...
New Strategy and Grant Opportunities
Osteosarcoma patients face the reality that significant progress in treatment outcomes has not been made in over 30 years. The Osteosarcoma Institute is pursuing strategies to capitalize on the latest developments in improving the outcomes for patients. Here is the...
OSI Inaugural Meeting
Inaugural meeting of Osteosarcoma Institute! Building strategy to bring near-term treatment options for current patients and long-term development of better, less toxic treatments for future patients.
Creation of the Osteosarcoma Institute Announced
FOR IMMEDIATE RELEASE November 09, 2017 Osteosarcoma Institute Launched with Seed Funding From The QuadW Foundation Dallas, TX and Maui, HI—In conjunction with the 2017 Connective Tissue Oncology Society (CTOS) Annual Meeting in Maui, Hawaii, the What Would Willie...